Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry
Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry
复制标题
DOI:
10.1016/j.humimm.2016.08.010
复制
发表时间:
2016-12-01
期刊:
影响因子:
2.7
通讯作者:
Fernando, Suran L.
中科院分区:
文献类型:
--
作者:
Dinh Van Nguyen;Vidal, Christopher;Fernando, Suran L.
Objectives: Screening for the HLA-B*15:02 allele has been recommended to prevent carbamazepine (CBZ) - induced Stevens Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in individuals with Asian ancestry. We aimed, therefore, to develop and validate a robust and inexpensive method for detection of the HLA-B*15:02 allele.Methods: Real-time PCR using TaqMan (R) probes followed by SYBR (R) Green was used to detect the HLA-B*15:02 allele prior to treatment with CBZ therapy.Results: A total of 121 samples were tested. The assay has a sensitivity of 100% (95% CI: 76.84-100.0%), a specificity of 100% (95% CI: 96.61-100%), a positive predictive value of 100% (95% CI: 76.84-100%) and a negative predictive value of 100.0% (95% CI: 96.61-100.0%), respectively. There was 100% agreement between our results and genotyping using Luminex SSO/SBT/SSP. The lowest limit of detection of the TaqMan (R) probe is 0.05 ng/mu l and the SYBR Green is 0.5 ng/mu l of DNA. The unit cost of using the TaqMan (R) probe followed by SYBR Green is only $4.7 USD.Conclusion: We developed a novel assay for the detection of the HLA-B*15:02 allele, which is robust, inexpensive and suitable for screening individuals of Asian ancestry in the prevention of CBZ-induced SJS/TEN. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.